Alexandra Bartels

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022 .

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?

C. Strassburg, G. Feldmann, P. Brossart, 2022, Journal of Cancer Research and Clinical Oncology.

Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

C. Strassburg, H. Matthaei, M. Gonzalez-Carmona, 2021, Cancers.

Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?

C. Strassburg, G. Feldmann, P. Brossart, 2022, Journal of Cancer Research and Clinical Oncology.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.

Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation

C. Strassburg, M. Gonzalez-Carmona, S. Manekeller, 2021, Medicine.

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis

C. Strassburg, G. Feldmann, H. Matthaei, 2021, Frontiers in Oncology.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.